Paraneoplastic pemphigus (Paraneoplastic autoimmune multiorgan syndrome): Clinical presentations and pathogenesis

Dermatologic Clinics

Volumn 29, Issue 3, 2011, Pages 419-425

  Frew, John W ^a,b   Murrell, Dédée F ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Lymphoproliferative disorders; Paraneoplastic autoimmune multiorgan syndrome; Paraneoplastic pemphigus

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNE SKIN DISEASE; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CONSENSUS; DETERIORATION; DIFFERENTIAL DIAGNOSIS; DRUG TARGETING; ERYTHEMA MULTIFORME; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LICHEN PLANUS; LYMPHOPROLIFERATIVE DISEASE; MORTALITY; PARANEOPLASTIC PEMPHIGUS; PATHOGENESIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; RARE DISEASE; REVIEW;

AUTOIMMUNE DISEASES; HEMATOLOGIC NEOPLASMS; HUMANS; MULTIPLE ORGAN FAILURE; PARANEOPLASTIC SYNDROMES; PEMPHIGUS;

EID: 79956268455     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.03.018     Document Type: Review

References (12)

1. Zimmerman J., Bahmer F., Rose C., et al. J Dtsch Dermatol Ges 2010, 8:598-605. [in German].
2. Anhalt G.J., Kim S.C., Stanley G.R., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990, 323:1729-1735.
3. Robinson N.D., Hashimoto T., Amagai M., et al. The new pemphigus variants. J Am Acad Dermatol 1999, 40:649-671.
4. Sehgal V.N., Srivastava G. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome. Int J Dermatol 2009, 48:162-169.
5. Nguyen V.T., Ndoye A., Bassler K.D., et al. Classification, clinical manifestations and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome. Arch Dermatol 2001, 137:193-206.
6. Joly P., Richard C., Gilbert D., et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000, 43:619-626.
7. Vezzoli P., Berti E., Marzano A.V. Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus. Expert Rev Clin Immunol 2008, 4(3):351-364.
8. Zhu X., Zhang B. Paraneoplastic pemphigus. J Dermatol 2007, 34:503-511.
9. Schaeppi H., Bauer J.W., Hametner R., et al. Localised variant of paraneoplastic pemphigus: acantholysis associated with malignant melanoma. Br J Dermatol 2001, 144:1249-1254.
10. Park G.T., Lee J.H., Yun S.J., et al. Paraneoplastic pemphigus without an underlying neoplasm. Br J Dermatol 2007, 156:725-732.
11. Wang L., Bu D., Yang Y. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 2004, 363:525-531.
12. Wang L., Bu D., Li T., et al. Autoantibody production from a thymom and dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 2005, 153:558-564.